Tilray BrandsWBO:TLR2 +1.91%55 PS Ratio is 0.57 as of Jun. 27, 2026, which is 84% below its 10-year median of 3.58. GuruFocus rates WBO:TLR2 with a GF Score™ of 55/100 and a GF Value™ of €10.57 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 953 Drug Manufacturers companies, Tilray Brands ranks better than 85.31% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Tilray Brands's share price is €3.995.
Tilray Brands's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was €6.99. Hence, Tilray Brands's PS Ratio for today is 0.57.
Good Sign:
Tilray Brands Inc stock PS Ratio (=0.58) is close to 1-year low of 0.58.
The historical rank and industry rank for Tilray Brands's PS Ratio or its related term are showing as below:
WBO:TLR2'
s PS Ratio Range Over the Past 10 Years
Min: 0.4 Med: 3.58 Max: 127.75
Current: 0.58
During the past 13 years, Tilray Brands's highest PS Ratio was 127.75. The lowest was 0.40. And the median was 3.58.
WBO:TLR2's PS Ratio is ranked better than 85.31% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.2
vs WBO:TLR2: 0.58
Tilray Brands Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Tilray Brands was -16.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -10.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -14.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 44.00% per year.
During the past 13 years, Tilray Brands's highest 3-Year average Revenue per Share Growth Rate was 160.10% per year. The lowest was -18.50% per year. And the median was 51.15% per year.
Back to Basics: PS Ratio
Tilray Brands (WBO:TLR2) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Tilray Brands PS Ratio Related Terms
Tilray Brands PS Ratio Historical Data
* Premium members only.
The historical data trend for Tilray Brands's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's PS Ratio distribution charts can be found below:
* The bar in red indicates where Tilray Brands's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Tilray Brands's Share Price of today is €3.995. Tilray Brands's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.99.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Tilray Brands (WBO:TLR2) has a PS Ratio of 0.57 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Tilray Brands and its competitors. This is 84% below median its historical median of 3.58. Over the past decade, Tilray Brands' PS Ratio has ranged from 0.40 to 127.75. According to the industry distribution chart, Tilray Brands ranks #140 out of 953 companies in the Drug Manufacturers industry, placing it in the top 14.7%.
Is Tilray Brands' PS Ratio too high?
Tilray Brands' current PS Ratio of 0.57 is 84% below median its 10-year median of 3.58. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 127.75. The Drug Manufacturers industry median PS Ratio is 2.20. Tilray Brands' value of 0.57 is 74.1% below this industry median. Based on the distribution chart, Tilray Brands ranks #140 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tilray Brands has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' PS Ratio compare to IRWD and BIOA?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #140 out of 953 companies for PS Ratio. This places Tilray Brands in the top 15% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.20. Tilray Brands' value of 0.57 is 74.1% below this benchmark. Historically, Tilray Brands' own PS Ratio has ranged from 0.40 to 127.75 over the past decade. While the company's 10-year median is 3.58 vs. the industry median of 2.20, Tilray Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tilray Brands's current PS Ratio of 0.57 is 74.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current PS Ratio is 0.57, which is 84% below median its own 10-year median of 3.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (WBO:TLR2) is currently considered Possible Value Trap. The stock's GF Value™ is €10.57, compared to a current price of €4.00 — trading 62.2% below its estimated fair value. The current PS Ratio is 0.57, which is 84% below median its 10-year median of 3.58 and 74.1% below the Drug Manufacturers industry median of 2.20. Tilray Brands' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Tilray Brands (WBO:TLR2), the current PS Ratio is 0.57 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (WBO:TLR2) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of €4.00 is trading 62.2% below its estimated GF Value™ of €10.57.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for WBO:TLR2:
PS Ratio: 0.57 (84% below median its 10-year median of 3.58)
GF Value™: €10.57 vs. price of €4.00 (62.2% below fair value)
Industry Position: 74.1% below the Drug Manufacturers median (#140 of 953)
No single metric tells the full story. See the WBO:TLR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
55GF Score
Get the complete analysis for WBO:TLR2
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:TLR2 has been successfully added to your 
